PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsMultiple sclerosis
MeSH D009103 - multiple sclerosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D020278:Cns demyelinating autoimmune diseases
0 Companies
0 Drugs
Success rate
D009103: 
Multiple sclerosis
D020528:Chronic progressive multiple sclerosis
0 Companies
0 Drugs
Success rate
D020529:Relapsing-remitting multiple sclerosis
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyMethylprednisolone Methylprednisolone  1982-01-01   
Prednisolone Prednisolone  1982-01-01   
Prednisone Prednisone  1982-01-01   
AAIPharmaAzathioprine Azasan  1999-06-07   
Abbott BiotherapeuticsMethylprednisolone A-methapred  1991-02-22   
AbbViePrednisolone Pred  1982-01-01   
Prednisolone Pred Mild  1982-01-01   
Accord HealthcareDalfampridine Dalfampridine  2018-07-11   
Fampridine Fampridine Accord  2020-09-24   
Dimethyl fumarate Dimethyl Accord  2023-02-15   
Alcon ResearchPrednisolone, Sulfacetamide Cetapred  1993-08-06   
Prednisolone, Sulfacetamide Isopto Cetapred  1982-01-01   
Prednisolone Prednisolone  1991-10-24   
Alembic PharmaceuticalsCyclophosphamide Cyclophosphamide  2022-11-10   
Alkem LaboratoriesAzathioprine Azathioprine  2020-03-27   
Dalfampridine Dalfampridine  2018-07-30   
AllerganPrednisolone, Sulfacetamide Blephamide  1986-12-03   
Prednisolone, Chloramphenicol Chloroptic-p  1982-01-01   
Prednisolone, Neomycin, Polymyxin b Poly-pred  1982-01-01   
Prednisolone, Gentamicin Pred  1988-06-10   
Baclofen Baclofen  1991-09-18   
Corticotropin Corticotropin  1984-11-21   
Dalfampridine Dalfampridine  2017-01-23   
Hydroxocobalamin Hydroxocobalamin  1982-01-01   
Methylprednisolone Methylprednisolone  1997-10-16   
Prednisolone Prednisolone  1982-01-01   
Prednisolone tebutate Prednisolone Tebutate  1984-02-17   
Prednisone Prednisone  1982-01-01   
1
2
3
4
5
6
...
16
>
Clinical Trials
Historical Success Rate
Phase 1
76%
68/90
Phase 2
45%
60/133
Phase 3
58%
71/123
Approved: 31Overall Success rate: 20%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
AbbVie
1
2
3
4
5
6
...
11
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use